𧬠CPT 52224 β Cystourethroscopy With Fulguration or Treatment of Minor (<0.5 cm) Lesion(s) With or Without Biopsy
Billable Code Confirmed
CPT 52224 is a valid, billable 5-character CPT for CY2026. This code describes cystourethroscopy with fulguration (including cryosurgery or laser surgery) or treatment of minor (less than 0.5 cm) lesion(s) with or without biopsy. No additional characters are required.
Non-Billable Parent Codes β Never Submit These
- β
52000β Diagnostic cystourethroscopy β bundled into 52224- β
52204β Cystourethroscopy with biopsy(s) β bundled into 52224 when performed at same session- β
52214β Cystourethroscopy with fulguration of trigone/bladder neck/prostatic fossa/urethra/periurethral glands β mutually exclusive with 52224Always submit 52224 (all 5 characters) when fulguration or treatment of minor (<0.5 cm) lesion(s) is documented.
Clinical Context: Minor Lesion Size Threshold
CPT 52224 captures fulguration or treatment of minor lesions less than 0.5 cm. The size threshold (<0.5 cm) is the critical distinction from 52234 (small tumors 0.5-2.0 cm). Documentation must explicitly state the lesion size is <0.5 cm to support 52224. If size is not documented, query the provider.
Code Classification
CPT Procedure Code β wRVU 5.26, Global Period 000, Assistant-at-Surgery: Not Payable. APC 5374 (J1). Facility-based professional fee only.
π Code Description
CPT 52224 classifies cystourethroscopy with fulguration (including cryosurgery or laser surgery) or treatment of minor (less than 0.5 cm) lesion(s) with or without biopsy. This code represents the lowest level of therapeutic endoscopic bladder intervention for lesions and includes biopsy if performed during the same session.
The procedure involves passing a cystoscope/resectoscope through the urethra to visualize the bladder, identifying minor lesions (<0.5 cm), and destroying them using electrocautery, laser, or cryotherapy. Biopsy may be performed if tissue sampling is indicated. This code is commonly used for small bladder tumors, polyps, or other minor lesions requiring destruction.
π³ Code Tree / Hierarchy
52000 Cystourethroscopy (separate procedure) β Non-billable when with 52224
β
βββ 52204 Cystourethroscopy with biopsy(s) β Bundled into 52224
β
βββ 52214 Cystourethroscopy with fulguration of trigone/bladder neck/prostatic fossa/urethra/periurethral glands β Mutually exclusive
β
βββ 52224 Cystourethroscopy with fulguration of minor (<0.5cm) lesion(s) β THIS CODE β
Billable
β
βββ 52234 Cystourethroscopy with fulguration/resection of small bladder tumor(s) (0.5-2.0cm) β
Billable
β
βββ 52235 Cystourethroscopy with fulguration/resection of medium bladder tumor(s) (2.0-5.0cm) β
Billable
β
βββ 52240 Cystourethroscopy with fulguration/resection of large bladder tumor(s) β
Billable
Size Documentation Is Critical
β Includes
The following clinical terms and scenarios map to 52224 when documented:
- Fulguration of minor bladder lesion (<0.5 cm)
- Treatment of lesion <0.5 cm
- Cryosurgery of minor bladder lesion
- Laser surgery of minor bladder lesion
- Biopsy with fulguration of minor lesion
- Destruction of small bladder polyp (<0.5 cm)
- Electrocautery of papillary bladder lesion (<0.5 cm)
β Excludes
Excludes 1 β Cannot Be Coded Simultaneously with 52224
| Code | Description | Note |
|---|---|---|
| 52000 | Cystourethroscopy (separate procedure) | Diagnostic cystoscopy is bundled into 52224; never bill together |
| 52204 | Cystourethroscopy with biopsy(s) | Biopsy bundles into 52224 when performed at same session |
| 52214 | Cystourethroscopy with fulguration of trigone/bladder neck/prostatic fossa/urethra/periurethral glands | Mutually exclusive β select the code that best describes the procedure |
Excludes 1 Violation Risk
The most common coding error is billing 52000 (diagnostic cystoscopy) with 52224. NCCI edits bundle 52000 into 52224. If both diagnostic and therapeutic cystoscopy are performed, only 52224 is reported. Another common error is using 52214 for bladder lesions when 52224 (tumor) or 52234-52240 (size-based tumor resection) is more appropriate.
Excludes 2 β May Be Coded in Addition if Separately Present
| Code | Description | Note |
|---|---|---|
| 51720 | Bladder instillation of anticarcinogenic agent | May be separately billable if performed in a distinct session later the same day; append modifier 59 |
π Clinical Overview
Bladder Lesion Size-Based Code Selection
| Feature | 52224 β Minor (<0.5cm) | 52234 β Small (0.5-2.0cm) | 52235 β Medium (2.0-5.0cm) | 52240 β Large (>5.0cm) |
|---|---|---|---|---|
| Lesion Size | <0.5 cm | 0.5-2.0 cm | 2.0-5.0 cm | >5.0 cm |
| Procedure Type | Fulguration/treatment | Fulguration/resection | Fulguration/resection | Fulguration/resection |
| wRVU (2026) | 5.26 | 6.49 | 7.62 | 10.30 |
| Complexity | Moderate | Moderate-High | High | High |
| Typical Setting | Office/ASC/HOPD | ASC/HOPD | ASC/HOPD | HOPD/Inpatient |
CDI Query Trigger β Size Documentation
When the operative note describes a βsmall bladder tumorβ or βlesionβ without exact measurements, a CDI query should request: βPlease specify the size of the bladder lesion in centimeters to support accurate CPT code selection (52224 <0.5cm, 52234 0.5-2.0cm, 52235 2.0-5.0cm, 52240 >5.0cm).β
Common Clinical Indications
- Bladder cancer surveillance: Small recurrent papillary tumors <0.5 cm
- Hematuria evaluation: Minor lesion identified as bleeding source
- Bladder polyp: Small polyp requiring destruction
- Condyloma: Small urethral/bladder condyloma
- Carcinoma in situ: Small flat lesions requiring fulguration
π° HCC Risk Adjustment (CMS-HCC v28)
| Field | Detail |
|---|---|
| CMS-HCC Model Version | v28 (2024-2025 Implementation) |
| HCC Assignment | β Not HCC-Mapped |
| HCC Category | N/A β CPT procedural code |
| RAF Coefficient | N/A |
52224 does not map to an HCC under v28 as it is a CPT procedure code, not a diagnosis code.
π₯ APC Assignment (Outpatient)
APC 5374 β Level 4 Urology Procedures (J1)
| Setting | Payment Rate | Status Indicator |
|---|---|---|
| Hospital Outpatient (OPPS) | ~$3,449 | J1 |
| ASC | ~$1,655 | J1 |
| Physician Facility | ~$176 | A |
| Physician Non-Facility | ~$761 | A |
Site-of-Service Impact
CMS 2026 PFS final rule reduced facility-based professional fees by ~9.6% for cystoscopy procedures while increasing OPPS/ASC facility payments by ~4.4%. Hospital-employed urologists see lower professional fees; independent ASC-based practices benefit from higher facility payments.
π Related CPT Codes
Bladder Tumor Resection Hierarchy
| Code | Description |
|---|---|
| 52224 | Cystourethroscopy with fulguration of minor (<0.5cm) lesion(s) β This Code |
| 52234 | Cystourethroscopy with fulguration/resection of small bladder tumor(s) (0.5-2.0cm) |
| 52235 | Cystourethroscopy with fulguration/resection of medium bladder tumor(s) (2.0-5.0cm) |
| 52240 | Cystourethroscopy with fulguration/resection of large bladder tumor(s) |
| 52204 | Cystourethroscopy with biopsy(s) (bundled into 52224) |
| 52214 | Cystourethroscopy with fulguration of trigone/bladder neck/prostatic fossa/urethra/periurethral glands (mutually exclusive) |
π οΈ Commonly Associated ICD-10-CM Diagnoses
Outpatient and Profee Setting Context
These ICD-10-CM codes commonly support medical necessity for CPT 52224 in the outpatient, ASC, and professional fee settings.
| ICD-10-CM | Description | Coding Notes |
|---|---|---|
| C67.0 | Malignant neoplasm of trigone of bladder | Primary bladder cancer |
| C67.1 | Malignant neoplasm of dome of bladder | Primary bladder cancer |
| C67.2 | Malignant neoplasm of lateral wall of bladder | Primary bladder cancer |
| C67.3 | Malignant neoplasm of anterior wall of bladder | Primary bladder cancer |
| C67.4 | Malignant neoplasm of posterior wall of bladder | Primary bladder cancer |
| C67.5 | Malignant neoplasm of bladder neck | Primary bladder cancer |
| C67.6 | Malignant neoplasm of ureteric orifice | Primary bladder cancer |
| C67.8 | Malignant neoplasm of overlapping sites of bladder | Primary bladder cancer |
| C67.9 | Malignant neoplasm of bladder, unspecified | Primary bladder cancer |
| D09.0 | Carcinoma in situ of bladder | Pre-malignant lesion |
| D30.3 | Benign neoplasm of bladder | Benign bladder tumor |
| D41.4 | Neoplasm of uncertain behavior of bladder | Uncertain behavior |
| R31.0 | Gross hematuria | Primary indication for cystoscopy |
| R31.1 | Benign essential microscopic hematuria | Hematuria workup |
| R31.2 | Other microscopic hematuria | Hematuria evaluation |
| R31.9 | Hematuria, unspecified | General hematuria indication |
| Z85.51 | Personal history of malignant neoplasm of bladder | Surveillance cystoscopy |
π¬ ICD-10-PCS Crosswalk (Inpatient Procedures)
When 52224 is performed in the inpatient setting, these PCS codes are relevant:
| PCS Section | Body System | Root Operation | Clinical Application |
|---|---|---|---|
| 0 β Medical and Surgical | T β Urinary System | 5 β Destruction | 0T5B8ZZ β Destruction of bladder, via natural or artificial opening endoscopic (fulguration of minor bladder lesion) |
| 0 β Medical and Surgical | T β Urinary System | B β Excision | 0TBB8ZZ β Excision of bladder, via natural or artificial opening endoscopic (if resection performed) |
π Coding Scenarios and Examples
Scenario 1 β Outpatient/ASC: Surveillance Cystoscopy With Minor Tumor Fulguration
Clinical Vignette: A 72-year-old male with history of non-muscle invasive bladder cancer (pTaG1) presents for routine surveillance cystoscopy. Cystoscopy reveals a 3mm papillary lesion on the right lateral wall. The urologist performs cold cup biopsy followed by fulguration of the base using a Bugbee electrode. Pathology later confirms recurrent low-grade papillary urothelial carcinoma.
CPT Codes:
- 52224 β Cystourethroscopy with fulguration of minor (<0.5cm) lesion with biopsy (primary procedure β biopsy bundled)
ICD-10-CM:
- Z85.51 β Personal history of malignant neoplasm of bladder (primary diagnosis β surveillance)
- C67.2 β Malignant neoplasm of lateral wall of bladder (secondary β confirmed malignancy)
Note: 52204 is NOT billed separately β biopsy is bundled into 52224. 52000 is NOT billed separately.
Scenario 2 β Outpatient: Hematuria With Minor Lesion
Clinical Vignette: A 65-year-old female presents with gross hematuria. Cystoscopy reveals a 4mm erythematous lesion at the bladder dome with active bleeding. The urologist performs fulguration using laser. No biopsy is performed. Imaging (CT urogram) was negative for upper tract lesions.
CPT Codes:
- 52224 β Cystourethroscopy with fulguration of minor (<0.5cm) lesion (primary procedure)
ICD-10-CM:
- R31.0 β Gross hematuria (primary diagnosis)
- N30.80 β Other cystitis without hematuria (secondary β if inflammatory component documented)
Note: If E/M service was significant and separately identifiable (e.g., new patient with complex hematuria workup), bill with modifier 25.
Scenario 3 β CDI Query: Missing Lesion Size
Clinical Vignette: Operative note states: βCystoscopy performed. Small papillary tumor seen on posterior wall. Resected and fulgurated.β No specific size documented. Pathology: βPapillary urothelial carcinoma, low grade.β
Action / Outcome: Coding uncertainty: Cannot determine if 52224 (<0.5cm), 52234 (0.5-2.0cm), 52235 (2.0-5.0cm), or 52240 (>5.0cm) is correct. CDI query sent to urologist.
Query Response: Provider clarifies: βTumor measured approximately 3mm (0.3cm) in greatest dimension.β
Corrected CPT Coding:
- 52224 β Cystourethroscopy with fulguration of minor (<0.5cm) lesion (accurate code after CDI clarification)
β οΈ Coding Pitfalls and Tips
| Pitfall or Tip | |
|---|---|
| β | Billing 52000 with 52224. Diagnostic cystoscopy is bundled into 52224. Never bill 52000 and 52224 for the same session. |
| β | Billing 52204 with 52224. Biopsy is bundled into 52224 when performed at same session. Do not bill 52204 separately. |
| β | Using 52224 without documented size. The <0.5cm threshold must be explicitly documented. If size is missing, query the provider. |
| β | Confusing 52214 with 52224. 52214 is for non-tumor fulguration at specific sites (trigone, bladder neck, etc.). 52224 is for minor lesions/tumors <0.5cm anywhere in the bladder/urethra. |
| β | Modifier -25 for E/M. A significant, separately identifiable E/M service on the same day may be billed with modifier -25. |
| β | Modifier -59 for distinct sites. If fulguration is performed at a completely separate anatomical site from another procedure, modifier -59 may apply. |
| β | Document exact size in cm. Always document lesion size in centimeters (not βsmall,β βtiny,β βpea-sizedβ) to support accurate code selection. |
| β | Modifier -22 for increased complexity. If the procedure requires significantly greater work than typical (e.g., multiple small lesions, difficult access), modifier -22 may be appended with supporting documentation. |
π Sources
1 CMS/NCHS. ICD-10-CM Official Guidelines for Coding and Reporting, FY2026. 2 AMA. CPT Professional Edition 2026. Surgery / Urinary System. 3 CMS. CY2026 Medicare Physician Fee Schedule Final Rule (CMS-1832-F). Addendum B. 4 CMS. 2026 Hospital Outpatient Prospective Payment System (OPPS) Final Rule. Addendum B, APC 5374. 5 CMS. 2026 Ambulatory Surgical Center (ASC) Payment System. Addendum AA. 6 CMS. National Correct Coding Initiative (NCCI) Policy Manual, Chapter 7 β CPT Codes 50000-59999. 7 AUA. Urology Coding and Reimbursement Guidelines 2026. 8 Boston Scientific. 2026 Coding and Payment Guide β Cystoscopy-Based Procedures.
Notes generated 2026-05-21. All payment rates are 2026 Medicare unadjusted national averages. Verify against local fee schedules and payer policies.
Crystal's Coder Hub